Edap Tms (NASDAQ:EDAP) Share Price Crosses Above 200 Day Moving Average - Here's Why

Key Points

• The stock price of Edap Tms S.A. (NASDAQ:EDAP) has crossed above its 200-day moving average, trading at $2.53 after reaching a high of $2.65.
• Edap Tms shares have seen a 7.9% increase recently, with a market cap of $94.45 million and a negative price-to-earnings ratio of -4.14.
• Institutional investors now hold 62.74% of the company's stock, with notable recent acquisitions by several firms, including a significant stake increase by Banque Transatlantique SA.

Edap Tms S.A. (NASDAQ:EDAP - Get Free Report)'s stock price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.83 and traded as high as $2.65. Edap Tms shares last traded at $2.53, with a volume of 43,998 shares changing hands.

Edap Tms Stock Up 3.5%

The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.05 and a current ratio of 1.51. The firm has a market cap of $98.34 million, a price-to-earnings ratio of -4.31 and a beta of -0.21. The firm has a fifty day simple moving average of $1.79 and a 200-day simple moving average of $1.82.

Institutional Trading of Edap Tms

Institutional investors and hedge funds have recently modified their holdings of the business. Millennium Management LLC lifted its holdings in Edap Tms by 218.5% in the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider's stock worth $108,000 after buying an additional 33,558 shares during the period. BNP Paribas Financial Markets lifted its position in shares of Edap Tms by 111.5% in the fourth quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider's stock valued at $108,000 after acquiring an additional 25,650 shares in the last quarter. Scoggin Management LP purchased a new stake in shares of Edap Tms in the first quarter worth about $686,000. Banque Transatlantique SA raised its position in Edap Tms by 7,063.7% during the first quarter. Banque Transatlantique SA now owns 730,699 shares of the medical equipment provider's stock valued at $1,324,000 after purchasing an additional 720,499 shares during the period. Finally, Cetera Investment Advisers grew its stake in Edap Tms by 33.9% in the first quarter. Cetera Investment Advisers now owns 75,000 shares of the medical equipment provider's stock worth $147,000 after purchasing an additional 19,000 shares in the last quarter. Hedge funds and other institutional investors own 62.74% of the company's stock.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.